Life Sciences Lunch Series
Bio-automation: Smart Technologies for Scientific Tasks
Bio-automation is a leading trend in the life science industry, and it is no longer just robotics for liquid handling. Using both hardware and software solutions, Bio-automation is tackling more sophisticated tasks replacing humans with smart technologies to speed drug research, improve clinical diagnostic data for the treatment of patients, increase quality and accuracy of outcomes and decisions. Bio-automation technology is being deployed across the industry with impressive results. Please join us as we hear from a variety of companies on how they are impacting life sciences.
- Randall Julian, CEO, Indigo BioSystems
- Mike Ashley, Chief Engineer for Automation, Beckman Coulter
- Justin Wiseman, CEO, Prosolia, Inc.
- Tim DeFrench, CEO, The RND Group
- Todd Vare, Partner, Barnes & Thornburg
When: Tuesday, April 21
Time: 11:30 a.m. Registration and Lunch | noon - 1 p.m. Presentation
Location: Barnes & Thornburg | 5th Floor Auditorium | 11 S Meridian, Indianapolis
Also available in other Barnes & Thornburg office in Chicago, and in cooperating facilities in Merrillville and New Albany.
If you register and become unable to attend, please email email@example.com.